Psoriasis Treatment Market Size Anticipated to Hit USD 37,634.2 Million with 9.2% CAGR by 2026; Rising Prevalence of Psoriasis Worldwide will Promote Growth | Fortune Business Insights™

Pune, India, Feb. 24, 2021 (GLOBE NEWSWIRE) -- The global psoriasis treatment market size is anticipated to touch USD 37,634.2 million by 2026 owing to the increasing number of psoriasis cases. Some studies say that psoriasis may further develop other chronic diseases that cause harm to the immune system of the body. These include non-melanoma skin cancer, psoriatic arthritis, lung cancer, depression, metabolic syndrome, cardiac disorders, COPD (chronic obstructive pulmonary disease), and others. It may also cause polycystic ovarian syndrome and pregnancy complications in women. A recent report by Fortune Business Insights offers a qualitative and quantitative analysis of this market and its growth parameters. According to this report, the market value stood at USD 18,378.0 million in 2018 and will exhibit a CAGR of 9.4% between 2019 to 2026.

The emergence of COVID-19 has brought the world to a standstill. We understand that this health crisis has brought an unprecedented impact on businesses across industries. However, this, too, shall pass. Rising support from governments and several companies can help in the fight against this highly contagious disease. Some industries are struggling, and some are thriving. Overall, almost every sector is anticipated to be impacted by the pandemic.

Request a Sample Copy of the Research Report:

We are making continuous efforts to help your business sustain and grow during COVID-19 pandemics. Based on our experience and expertise, we will offer you an impact analysis of coronavirus outbreak across industries to help you prepare for the future.

Major Industry Developments of the Psoriasis Treatment Market include:

February 2019 – FDA approved the use of TREMFYA, an injector that can be controlled by the patient single-handedly by Janssen Pharmaceuticals, a part of Johnson & Johnson Services Inc., for treating both severe and moderate cases of Psoriasis.

April 2019 – Duobrii the first and only lotion for adults suffering from psoriasis manufactured by Ortho Dermatologics received FDA approval.

TNF Inhibitors Segment to be Overpowered in Forecast Years Due to Declining Prices of Branded Products

Based on segmentation by drug class, the TNF inhibitors segment was dominating the market in the past. In 2018, this segment earned a 46.3% psoriasis treatment market share. However, the advent of biosimilar and increasing prescription volume for interleukin inhibitors resulted in a decline in the rate of branded products. Owing to the factor stated above, the interleukin inhibitors segment is likely to overpower the TNF inhibitors segment in the coming years.

Click here to get the short-term and long-term impact of COVID-19 on this Market.
Please visit:

North America to Dominate Market on Account of Presence of Strong Healthcare Facilities

The National Psoriasis Foundation states an estimate of 8 million Americans who are suffering from psoriasis. The increasing number of people suffering from this disease in America and Canada is responsible for the dominance of the North American market. Besides this, the presence of strong healthcare facilities, the adoption of biological therapies at a high rate, and the heavy investments in research and development, and clinical trials are also boosting the regional market.

Quick Buy Psoriasis Treatment Market Research Report:

Europe emerged as the second largest market and Asia Pacific is likely to register faster growth rates in the coming years on account of the rise in geriatric population, improving healthcare and medical facilities, and the adoption of high tech medical equipment for various diagnostic procedures.

Fortune Business Insights™ lists out the names of players operating in this market. They are as follows:

  • Amgen Inc.
  • Sun Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.
  • Eli Lilly and Company
  • UCB S.A.
  • Novartis AG
  • LEO Pharma A/S
  •  AbbVie Inc.
  • Johnson & Johnson Services, Inc.
  • Pfizer Inc.
  • Other players

Have Any Query? Ask Our Experts:

Detailed Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Prevalence of Psoriasis and Psoriatic Arthritis for Key Countries/Region
    • Recent Industry Developments Such as Partnerships, Mergers & Acquisitions, New Product Launches Etc.
    • Pipeline Analysis for Key Companies
    • Regulatory Framework by Key Countries
    • Global Reimbursement Scenario
  • Global Psoriasis Treatment Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Drug Class
      • TNF Inhibitors
      • Interleukins
      • Others
    • Market Analysis, Insights and Forecast – By Type
      • Plaque Psoriasis
      • Psoriatic Arthritis
      • Others
    • Market Analysis, Insights and Forecast – By Route of Administration
      • Oral
      • Parenteral
      • Topical
    • Market Analysis, Insights and Forecast – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online pharmacies
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia pacific
      • Latin America
      • Middle East & Africa
  • North America Psoriasis Treatment Market Analysis, Insights and Forecast, 2015-2026
    • Key Findings / Summary
    • Market Analysis – By Drug Class
      • TNF Inhibitors
      • Interleukins
      • Others
    • Market Analysis – By Type
      • Plaque Psoriasis
      • Psoriatic Arthritis
      • Others
    • Market Analysis – By Route of Administration
      • Oral
      • Parenteral
      • Topical
    • Market Analysis – By Distribution Channel
      • Hospital Pharmacies
      • Retail Pharmacies
      • Online pharmacies
    • Market Analysis – By Country/Sub-region
      • U.S.
      • Canada

TOC Continued…!

Get your Customized Research Report:

Have a Look at Related Reports:

Insulin Pump Size, Share & Industry Analysis, By Product Type (Pumps (Tethered Pumps, Patch Pumps, and Others), and Consumables), By Disease Indication (Type 1 Diabetes and Type 2 Diabetes), By Distribution Channel (Hospital Pharmacy Retail Pharmacy, and Online Stores), and Regional Forecast, 2020-2027

Medical Equipment Financing Market Size, Share & Industry Analysis, By Device Type (Diagnostic Equipment, Therapeutic Equipment, Patient Monitoring Equipment, and Others), By End User (Hospitals & Clinics, Laboratories and Diagnostic Centers, and Others), and Regional Forecast, 2020-2027

Prefilled Syringes Market Size, Share & Industry Analysis, By Material (Glass and Plastic) By Closing System (Staked Needle System, Luer Cone System, and Luer Lock Form System) By Product (Complete Syringe Set and Components & Accessories) By Design (Double-chamber, Multiple-chamber, and Single-chamber) By End-user (Pharmaceutical & Biotechnology Companies, Contract Research & Manufacturing Organizations, and Others) and Regional Forecast, 2019-2026

Anticoagulants Market Share & Industry Analysis, By Disease Indication (Pulmonary Embolism (PE), Deep Vein Thrombosis (DVT), Atrial Fibrillation, Heart Attacks, Others), By Route of Administration (Oral, Injectable), By Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, Online Pharmacies, Others) and Regional Forecast, 2019-2026

About Us:

Fortune Business Insights™ offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them to address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights™ we aim at highlighting the most lucrative growth opportunities for our clients. We, therefore, offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.

US :+1 424 253 0390
UK : +44 2071 939123
APAC : +91 744 740 1245
Fortune Business Insights™
LinkedIn | Twitter | Blogs

Press Release:

Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.